Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

279
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
279

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Left ventricular perforation after transatrial delivery of a balloon-expandable valve.

JTCVS structural and endovascular·2026
Same author

Redo surgical aortic valve replacement versus valve-in-valve transcatheter aortic valve replacement with balloon valve fracture: Short-term clinical outcomes.

JTCVS structural and endovascular·2026
Same author

Valve-in-Valve TAVR Versus Redo Surgery in Women With Degenerated Aortic Bioprosthesis: A Single-Center Experience.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Minimally Invasive Approach for Mitral Valve Surgery Is Associated With Increased Risk of Postoperative Diaphragm Dysfunction.

Innovations (Philadelphia, Pa.)·2026
Same author

Porcelain Aorta in TAVR: Predictor of Adverse Outcomes or Overestimated Risk Factor?

Medicina (Kaunas, Lithuania)·2026
Same author

Modification of internal RNA domains from the long non-coding RNA XIST refines roles in silencing and heterochromatin recruitment.

Human molecular genetics·2026

相关实验视频

Updated: Sep 9, 2025

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
09:04

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg

Published on: November 19, 2019

8.8K

冠状动脉旁路移植的末期脏病患者的存活益处

Christine Yang1, Sameer Singh1, Takuya Ogami2

  • 1Division of Cardiothoracic Surgery, Department of Surgery, Columbia University Medical Center, New York, New York.

The Annals of thoracic surgery
|September 4, 2025
PubMed
概括

对于接受冠状动脉旁路移植的末期病患者,左侧内部乳腺动脉移植比非移植患者的SVG治疗提供了较早的生存益处. 多动脉移植没有显著的生存优势.

更多相关视频

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs
08:44

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs

Published on: June 23, 2022

3.2K
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

7.9K

相关实验视频

Last Updated: Sep 9, 2025

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
09:04

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg

Published on: November 19, 2019

8.8K
Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs
08:44

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs

Published on: June 23, 2022

3.2K
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

7.9K

科学领域:

  • 心血管外科
  • 肝脏病学
  • 移植医学

背景情况:

  • 末期病 (ESRD) 显著增加了冠状动脉旁路移植 (CABG) 患者的风险.
  • 在ESRD患者中,动脉移植与纯静脉移植 (SVG) 的生存优势仍然不确定.
  • 移植对ESRD患者的长期存活有显著影响.

研究的目的:

  • 为了比较医院和长期生存结果.
  • 在接受CABG的ESRD患者中评估动脉移植策略 (LIMA+SVG,MAG,仅SVG).
  • 评估移植和非移植ESRD患者队列的结果.

主要方法:

  • 使用美国脏数据系统 (USRDS) 来获取2015-2021年的数据.
  • 分析了随后移植状态的单独的CABG患者.
  • 使用逆治疗概率权衡 (IPTW) 来平衡基线特征.

主要成果:

  • 在非移植ESRD患者中,左内乳动脉 (LIMA) 移植显示出5年存活率优于仅SVG (31. 6%对比26. 6%; p < 0. 001).
  • 在基准分析中,该LIMA优势在4年后减少.
  • 与LIMA相比,多动脉移植 (MAG) 在移植或非移植ESRD患者中没有显著的5年生存益处.

结论:

  • 在接受CABG的非移植ESRD患者中,LIMA移植具有早期生存益处.
  • 有限的证据表明,无论移植状态如何,MAG在ESRD患者中都不会比LIMA提供生存优势.
  • 在接受CABG的ESRD患者中,需要仔细考虑动脉移植策略.